New cancer clinical trial: Prostate Cancer Biomarker Enrichment and Treatment Selection

Published on: December 28, 2017 at 10:00AM
Condition:   Prostate Cancer
Interventions:   Drug: AZD1775;   Drug: Savolitinib;   Drug: Darolutamide
Sponsors:   Canadian Cancer Trials Group;   Canadian Cancer Clinical Trials Network;   BC Cancer Foundation
Not yet recruiting
http://ift.tt/2BTO0b9